Institutional investors purchased a net $1.9 million shares of SGEN during the quarter ended June 2014 and now own 103.91% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CCR ASSET MANAGEMENT SA Bought 6.0 Thousand shares of Seattle Genetics Inc
CREDIT SUISSE AG Bought 300.00 shares of Seattle Genetics Inc
PHARUS MANAGEMENT SA Sold 1.8 Thousand shares of Seattle Genetics Inc